Roche buys alternative-site diabetes monitoring company
This article was originally published in Clinica
Executive Summary
Roche has bought private diabetes monitoring company Amira Medical for an undisclosed amount. The company has developed technology enabling users to draw a small blood sample from areas of the body other than the fingertip - a major problem for diabetics as there are more nerve endings in fingertips. Diabetes has provoked considerable interest this year, with Johnson & Johnson, Medtronic and now Roche making acquisitions in this area.